Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without antiplatelet therapy: Results from KORAFII registry

BACKGROUND: Studies have shown that the concomitant use of a vitamin K antagonist (VKA) and an antiplatelet (APL) drug increased the bleeding risk and was less effective at preventing ischemic events. This study aimed to investigate the control status of international normalized ratio (INR) and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hee‐Soon, Kim, Young‐Hoon, Kim, June Soo, Oh, Yong‐Seog, Shin, Dong‐Gu, Pak, Hui‐Nam, Hwang, Gyo‐Seung, Choi, Kee‐Joon, Oh, Seil, Kim, Jin‐Bae, Lee, Man‐Young, Park, Hyung‐Wook, Kim, Dae‐Kyeong, Jin, Eun‐Sun, Park, Jae‐Seok, Oh, Il‐Young, Shin, Dae‐Hee, Park, Hyoung‐Seob, Kim, Jun Hyung, Kim, Nam‐Ho, Ahn, Min‐Soo, Seo, Bo‐Jeong, Kim, Young‐Joo, Kang, Seongsik, Lee, Juneyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686287/
https://www.ncbi.nlm.nih.gov/pubmed/31410229
http://dx.doi.org/10.1002/joa3.12183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686287/
https://www.ncbi.nlm.nih.gov/pubmed/31410229
http://dx.doi.org/10.1002/joa3.12183

Ejemplares similares